Below is an educational, technical answer to a question many patients and clinicians ask. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Coronary Artery Disease and Percutaneous Coronary Intervention
Contemporary practice relies heavily on drug-eluting stents, which release an antiproliferative agent to limit the tissue overgrowth that can cause restenosis. Percutaneous coronary intervention (PCI) is a catheter-based approach that reaches the coronary arteries through a small arterial access point, typically the radial or femoral artery. When a narrowing becomes flow-limiting, patients may experience angina on exertion, and an abrupt plaque rupture with thrombosis can precipitate a myocardial infarction.
Can a stented artery block again?
Yes, a stented segment can re-narrow through in-stent restenosis, in which tissue grows through and around the stent struts. Drug-eluting stents were developed specifically to reduce this risk compared with bare-metal designs. If restenosis occurs, it can often be treated with repeat angioplasty, a drug-coated balloon, or additional stenting as judged appropriate. Ongoing follow-up with the cardiologist helps detect and manage any recurrence.
What This Means in Practice
Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes. Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy. All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU.
Key Considerations
- Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting.
- Thin-strut cobalt-chromium platforms are intended to balance deliverability with radial support in a range of vessel sizes.
- Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy.
Frequently Asked Questions
What is the reported restenosis performance of the ATLAS DES?
INVAMED reports clinical data showing target lesion revascularization rates below 5% at 12 months; this reflects studied performance and is not an individual guarantee.
Are these coronary devices CE marked?
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Does INVAMED make a drug-coated coronary balloon?
Yes. The Extender Drug Eluting PTCA Balloon Catheter carries a paclitaxel coating for local drug delivery, such as in-stent restenosis or small-vessel disease.
Clinical and Technical Context
Lesion calcification is a central factor in planning, and heavily calcified plaque may call for rotational atherectomy before ballooning or stenting. INVAMED's AngioTEN Vascular Closure System is positioned for this access-site management role. According to INVAMED, clinical data for the ATLAS DES show target lesion revascularization rates below 5% at 12 months, a figure that reflects studied performance rather than an individual guarantee. Contemporary practice relies heavily on drug-eluting stents, which release an antiproliferative agent to limit the tissue overgrowth that can cause restenosis. All INVAMED coronary devices are intended for use by trained interventional cardiologists under fluoroscopic guidance and per the IFU. Whether a closure device is used, and which type, is determined by access site, sheath size, and clinician preference. Guide extension catheters can provide the backup support needed to deliver devices in tortuous or distal anatomy. Plaque modification is typically a preparatory step, and its use is decided by the operator based on the calcium burden seen on imaging.
Related on INVAMED
- Coronary Artery Disease & Cardiac Interventions — product category
- Drug-Eluting Stent (DES) Technology: Technology, Uses and Considerations
- AngioTEN Vascular Closure System — Technical Overview
- Sourcing Coronary Artery Disease & Cardiac Interventions Devices: A Manufacturer and Procurement Guide
Important Disclaimer
This content is educational and technical in nature and must not be interpreted as medical advice or as a promise of any clinical outcome. Individual results depend on many factors and can only be evaluated by a treating physician. Figures attributed to INVAMED reflect manufacturer or published data and are not a guarantee of results. All INVAMED devices are to be used by trained clinicians per the approved IFU, and availability is subject to local regulatory status.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.